Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis

Fig. 3

A: A CCK-8 assay was used to determine tumour cell growth. B: Transwell assay; tumour cells in the lower chamber were viewed at 10× magnification, “*” indicates P < 0.05. C: Immunohistochemical grading control D-G: Immunohistochemistry of subcutaneous tumour tissue (control), brain parenchyma metastatic tissue, and leptomeningeal metastatic tissue at 10x objective and 63x objective, respectively: (D) CD56 primary antibody (P = 0.88); (E) SYP primary antibody; (F) CHGA primary antibody (P = 0.58); (G) INSM1 primary antibody (P = 0.33)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us